Navigation Links
New Laser Treatment for Cellulite Helps Fight the Battle
Date:7/29/2009

The SmoothShapes® System is being introduced at the Juva Skin & Laser Center based in NYC. This procedure is the result of seven years of testing, is pain-free, and uses a dynamic combination of laser and light energy and along with other techniques.

(PRWEB) July 29, 2009 -- Juva Skin & Laser Center announced today that Dr. Bruce Katz is now offering a new and advanced laser treatment for cellulite. The SmoothShapes® system, perfected after seven years of development, targets longer-lasting improvement in dimpled skin known as cellulite. More than 85 percent of women will develop cellulite at some point in their lives, and it can't be controlled or improved through diet or exercise. Ultra slender supermodels, women devoted to a healthy lifestyle and diet, and even toned athletes can all have cellulite.

"After evaluating the technology and the clinical results, I found that SmoothShapes is an effective treatment for cellulite," said Dr. Katz. "Patients enjoy it because it frees them of cellulite without downtime, discomfort, or side effects. The unique combination of laser and dynamic light therapy, in addition to contoured rollers and suction, give results that provide longer-lasting cellulite reduction, without the need for monthly maintenance."

The new pain-free treatment uses a combination of dynamic energy and mechanical manipulation to rejuvenate collagen and improve the appearance of cellulite. SmoothShapes is different from other systems because its technology, the 915nm laser and the 650nm light plus vacuum and mechanical manipulation are known for impacting enlarged fat cells and inflexible collagen.

"Patients of every age are concerned about this pro
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Los Angeles Surgeon Dr. Rezaian - Pioneers Cutting Edge Laser Back Surgery (laserbacksurgery.com)
2. Cold Laser Technology Made Even More Accessible with Powerful New Product Available from Laser-Therapy.US
3. West Los Angeles Dental Practice Adds ezlase Laser Treatment to its Services
4. Assara Laser Hair Removal Centers (New York, NY) Receives 2008 New York Award for Cosmetology & Personal Hygiene Salons by the U.S.C.A.
5. American Laser Centers Announces Launch of ALC University
6. Lumenis, Worlds Largest Medical Laser Company, Honored by Premier Healthcare Alliance for Exceeding Performance Expectations
7. Lutronic(R) Becomes Official Laser for Lifestyle Lift(R)
8. Fractional co2 Laser Offers Cosmetic Treatments with Minimal Downtime For Melbourne Patients
9. Leading Los Angeles Clinic (laserandveinclinic.com) Provides Top Notch Aesthetic Laser Surgery
10. Skinovative(R) Announces a Safe Non-Surgical Liposuction Alternative With the Launch of Zerona(TM) Laser.
11. Lumenis High Speed LightSheer(R) Duet(TM) Featured on ABCs Good Morning America Health as the New Gold Standard for Laser Hair Removal

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Laser Treatment for Cellulite Helps Fight the Battle
New Laser Treatment for Cellulite Helps Fight the Battle
(Date:11/23/2009)...re open on-the-job interaction might ease the prob... (HealthDay News) -- Men who bottle up their anger...eir hearts, a new Swedish study indicates. , Me...ent over conflicts with a fellow worker or supervi... attack or die of heart disease as those who vente...
(Date:11/23/2009)...,, ClinicsContinuetoTargetIndividualsintheRecom.../PRNewswire-USNewswire/--TheDepartmentofHealthanno...ationclinicsatlocalStateHealthCentersinDelaware,La...sday,Nov.25.TheH1N1vaccinewillbeadministeredforfre...nothadpreviousaccesstothevaccine.Thedepartmentasks...
(Date:11/23/2009)...Three quarters of cancer patients and survivors tr...isorders that often become chronic conditions, hin...ng to scientists at the University of Rochester Me...howed they experienced sleep troubles at nearly th...problem was more prevalent in younger patients and...
(Date:11/23/2009)...NEW YORK (Nov. 23, 2009) -- A first-of-its-kind co... online today in the Annals of Surgery . The repo...onal consensus conference -- Diabetes Surgery Summ...han 50 scientific and medical experts agreed on a ...hat are meant to guide the use and study of gastro...
(Date:11/23/2009)...rtnerships doubled number of patients who reined i...MONDAY, Nov. 23 (HealthDay News) -- High blood pre...ams working hand-in-hand than by doctors and pharm...n physicians work with pharmacists, medications ar... more effectively," said Barry L. Carter, a profes...
Breaking Medicine News(10 mins):Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3
... be enough to prevent the loss of vision and even ... a new study has shown. When researchers ... wild salmon, sardines, anchovies and other coldwa...enetically-modified lab rodents showed no ill side...
... bmj.com today (Tuesday 26 June) questions the val... well-controlled, non-insulin dependent (type 2) d...ay at the American Diabetes Association Conference...y develops in people over 40, especially when the ...
... Benoit killed his wife and young son over the wee... World Wrestling Entertainment, Inc. has reporte...Chris, Nancy, and seven-year-old Daniel in their h... that the deaths were the result of a double murde...
...l Radcliffe, Emma Watson and Rupert Grint admit th...t their age do - drinking and smoking . Ho...of other young stars, is that they maintain their ...s that unlike a lot of young stars, the trio didn'...
...hat a class of commonly prescribed antidepressants...n older men and women . The antidepressant... inhibitors (SSRIs) treat depression by inhibiting...which has recently been discovered in bone as well...
...illegal drugs has said that opium production in Af...World Drug Report says over 90 percent of illegal ...ghanistan. According to a BBC report, the...t Afghanistan is unlikely to regain real security ...
Other Medicine News:Health News:Eating Fish Oil can Save Eyesight: Study 2Health News:Questions Over Value of Glucose Monitoring for Non-insulin Using Diabetes Patients 2Health News:Common Antidepressants Linked to Increased Bone Loss in Older Adults 2Health News:Common Antidepressants Linked to Increased Bone Loss in Older Adults 3
(Date:11/23/2009)...tCall/--AccurayIncorporated(Nasdaq: ARAY ),aglobal...tsmanagementisscheduledtopresentatthe21stAnnualPip...cember1,2009at9:00a.m.ET/6:00a.m.PT.Thecompanywill...NewYorkonThursday,December3,2009at3:00p.m.ET/12:00...availableonlinefromtheinvestorrelationspageoftheCo...
(Date:11/23/2009)...FirstCall/--TransceptPharmaceuticals,Inc.(Nasdaq: ...U.S.FoodandDrugAdministration(FDA)onJanuary20,2010...rugApplication(NDA)for Intermezzo ® (zolpide...heCompleteResponseLetter,receivedbyTransceptonOcto...Ainitspresentform.TheNDAseeksapprovaltomarket Inte...
(Date:11/23/2009)...r.comannouncesthatanewmarketresearchreportisavaila...ImagingMarketto2015 ,, http://www.reportlink...ng-Market-to-2015.html#utm_source=prnewswire&u... Description ,, TheFutureoftheDiagnosticImagi...Direct,s"TheFutureoftheDiagnosticImagingMarketto20...
Breaking Medicine Technology:Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference 2Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11Cardio Vascular Medical Device to Apply for Additional Patents in Europe Canada and Far East 61861 1Cardio Vascular Medical Device to Apply for Additional Patents in Europe Canada and Far East 61861 2Nevada Health Care Association 28NHCA 29 Supports Majority Leader Reid 61859 1Veridiam Wins Workplace Excellence Crystal Award in Mid Size Company Category 14935 1Veridiam Wins Workplace Excellence Crystal Award in Mid Size Company Category 14935 2
...orted Trial Enrollment Advancing Ahea...1 Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) ... company,s ongoing Phase 2 clinical trial of its l...), in platinum-resistant ovarian,cancer patients a...ASCO),Annual Meeting in Chicago, Illinois., "Vore...
..., COLLEGEVILLE, Pa., May 31 Wyeth,Pharmaceutical...ced results,of a three-arm phase 3 clinical trial ... mantle cell lymphoma (MCL), a form of non-Hodgkin...et of rapamycin) inhibitor,TORISEL(R) (temsirolimu...ment in median progression-free survival (PFS), co...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 2New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 3New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 4New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 5New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 6
Magnesium (Liquid)
LDH
LD Lactate –> Pyruvate
Anti-Streptolysin O (ASO)
Medicine Products: